HONG KONG — A new technology promises to deliver levodopa at more constant levels over time. It depends on a folded, accordion-like structure inside a gelatin capsule. When swallowed, the capsule ...
Acorda Therapeutics ($ACOR) moved a step closer to collecting the payoff from its $525 million acquisition of Civitas, maker of an inhaled levodopa, in the scramble ...
Parkinson’s disease progression is increasingly recognised as not only a consequence of genetic and pharmacological factors but also as being shaped by dietary choices. Nutritional interventions can ...
RODEN, Netherlands, Jan. 18, 2024 /PRNewswire/ -- PureIMS, a pharmaceutical company focused on the development of innovative inhalation products, this week reported it has completed a comparative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results